Boehringer Ingelheim has announced the launch of opnME.com, a new platform offering free and open access to selected pre-clinical molecules for non-clinical investigation to scientists worldwide. Through opnME.com, molecules for some of the most relevant targets in biomedical research are shared, thereby creating possibilities for further independent and collaborative discovery as well as the identification of novel treatment approaches for patients.
The Bundesnetzagentur prohibits the sale of children's watches that have an "eavesdropping" function and has already taken action against several offers on the internet. "Parents can use these children's watches to listen in to the child's surroundings without detection via an app. The watches are regarded as unauthorised transmitting equipment," said Jochen Homann, Bundesnetzagentur President. "Our investigations found, for example, that parents were using them to eavesdrop on teachers in lessons."
Roche (SIX: RO, ROG; OTCQX: RHHBY) has announced an agreement with Viewics, Inc., a privately held software company focused on laboratory business analytics. Under the agreement, Roche is acquiring all shares of the company. The acquisition, which is subject to customary closing conditions, is expected to close on November 21, 2017.
Bittium exhibited its innovative products and solutions for cardiology at Medica 2017 on November 13-16 in Dusseldorf, Germany. At the event Bittium has showcased Bittium Faros ECG devices and the recently launched Bittium Cardiac Explorer software for analyzing Cardiac event based ECG recording and Bittium Cardiac Navigator software meant for accurate analyzing of long-term Holter ECG recordings.
The healthcare industries cluster - HealthCapital Berlin-Brandenburg celebrates its 10 years anniversary. However, the tradition of the joint work of the States of Berlin and Brandenburg in the field of biotechnology and medical technology already goes back more than 20 years. During this time, the German capital region developed into one of the most dynamic metropolitan areas in Europe that stands for cosmopolitanism, innovation, creativity, and start-ups.
Dynamism alone, however, is not enough to master a successful future. The capital region is also transforming its dynamic development into high-quality growth in science and industry.
13 - 16 November 2017, Düsseldorf, Germany.
The U.S. Food and Drug Administration has approved the first drug in the U.S. with a digital ingestion tracking system. Abilify MyCite (aripiprazole tablets with sensor) has an ingestible sensor embedded in the pill that records that the medication was taken. The product is approved for the treatment of schizophrenia, acute treatment of manic and mixed episodes associated with bipolar I disorder and for use as an add-on treatment for depression in adults.
| Location: | Berlin, Germany |
| Job Type: | Full-Time |
| Employer: | Amgen |